Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Lung Cancer. 2017 Mar 29;108:173–182. doi: 10.1016/j.lungcan.2017.03.017

Figure 2. The use of chemoradiation regimens and sequences for stage III non-small-cell lung cancer over time.

Figure 2

Prevalence of: a) the most commonly employed platinum-based chemoradiation regimens and b) chemoradiation sequences used from 2002–2009 for stage III NSCLC. Data points representing <11 patients not shown to protect patient identity.